US Patent Issued to ONCOBIX on Sept. 23 for "Heterocyclic-substituted pyrimidine derivative exhibiting cancer cell growth inhibitory effect, and pharmaceutical composition containing same" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,221, issued on Sept. 23, was assigned to ONCOBIX Co. LTD. (Yongin-si, South Korea).

"Heterocyclic-substituted pyrimidine derivative exhibiting cancer cell growth inhibitory effect, and pharmaceutical composition containing same" was invented by Sung-Eun Kim (Seoul, South Korea), Sunho Lee (Seoul, South Korea), Rengasamy Rajesh (Suwon-si, South Korea), Yong Hyub Lee (Goyang-si, South Korea) and Sung Tak Hong (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a novel compound represented by Chemical Formula 1 or a salt thereof and a pharmaceutical composition for treating lung cancer containing same. A p...